Market Overview:
Benzathine cloxacillin intramammary infusion is a type of antibiotic that is used to treat infections in the mammary gland. It is available as a 10ml：0.5g and 250m1：12.5g dose, and can be administered through a retail or online sale channel, or used in other applications. The global benzathine cloxacillin intramammary infusion market is expected to grow at a CAGR of 5% during the forecast period 2018-2030.
Product Definition:
Benzathine cloxacillin intramammary infusion is a form of antibiotic that is used to treat infection in the mammary gland area of the cow. The antibiotic helps to clear up the infection and improve milk production.
10ml：0.5g:
10ml：0.5g, it's usage and growth factor in Benzathine Cloxacillin Intramammary Infusion market? 10 ml 0.5 g is a form of cloxacillin used for the treatment of bacterial infections in animals as well as people. It is administered parenterally by subcutaneous or intravenous injection into the vein or muscle tissue.
250m1：12.5g:
250m1：12.5g is a form of cloxacillin used for the treatment of bacterial infections in animals and humans. It can be administered to both adults and children as it does not affect the maturity level of the human body.
Application Insights:
The retail application segment led the market in 2017 and is projected to witness significant growth over the forecast period. The growing use of benzathine cloxacillin intramammary infusion for treating susceptible strains of lactose-fermenting bacteria in dairy animals is expected to be a major factor driving demand. Benzathine cloxacillin also finds applications in human medicine, wherein it is used for various conditions, including urinary tract infections (UTIs) and skin infections caused by staphylococcal bacteria.
Online sale accounted for 21% share of the global benzathine cloxacillin intramammary infusion market revenue in 2017 owing to an increase in awareness about antibiotics among consumers, coupled with rising penetration of e-commerce platforms globally.
Regional Analysis:
North America dominated the global benzathine cloxacillin intramammary infusion market in 2017. The presence of a large number of dairy farms and high adoption rate for technologically advanced products are some factors responsible for its largest share. Moreover, increasing incidence of mastitis in this region is also expected to drive demand over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to an increase in awareness about antimicrobial resistance among farmers and consumers as well as government support towards R&D activities related to veterinary drugs. Furthermore, low production costs due to availability of raw materials such as penicillin-strengthened cattlehide are also expected favorably impact regional growth over the next seven years.
Growth Factors:
- Increasing incidence of mastitis: Mastitis is a common infection in dairy cows that can cause significant economic losses to the dairy industry. The incidence of mastitis is increasing due to the increased use of antibiotics and the high prevalence of antibiotic-resistant bacteria. Benzathine cloxacillin intramammary infusion is an effective treatment for mastitis and has a low incidence of adverse effects.
- Growing demand for organic milk: There is growing demand for organic milk, which does not contain antibiotics or other synthetic chemicals. Benzathine cloxacillin intramammary infusion is an effective treatment for mastitis in organic dairy herds and does not contaminate the milk with residues from antibiotics.
- Increased use of cow-side milking systems: Cow-side milking systems are becoming more popular because they improve milk quality and reduce labor costs. However, they also increase the risk of mastitis because bacteria can spread more easily between cows when they are being milked side by side.. Benzathine cloxacillin intramammary infusion is an effective treatment for mastitis in herds using cow-side milking systems..
Scope Of The Report
Report Attributes
Report Details
Report Title
Benzathine Cloxacillin Intramammary Infusion Market Research Report
By Type
10ml：0.5g, 250m1：12.5g
By Application
Retail, Online Sale, Others
By Companies
Boehringer Ingelheim, Zoetis, Merck, Fresenius Kabi iPSUM, Oriental Aolong, Huisheng Biological, Zhengzhou Bairui Animal Pharmaceutical Co., Ltd., ·
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Benzathine Cloxacillin Intramammary Infusion Market Report Segments:
The global Benzathine Cloxacillin Intramammary Infusion market is segmented on the basis of:
Types
10ml：0.5g, 250m1：12.5g
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail, Online Sale, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boehringer Ingelheim
- Zoetis
- Merck
- Fresenius Kabi iPSUM
- Oriental Aolong
- Huisheng Biological
- Zhengzhou Bairui Animal Pharmaceutical Co., Ltd.
- ·
Highlights of The Benzathine Cloxacillin Intramammary Infusion Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10ml：0.5g
- 250m1：12.5g
- By Application:
- Retail
- Online Sale
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Benzathine Cloxacillin Intramammary Infusion Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Benzathine Cloxacillin Intramammary Infusion is a medication given to women to prevent infections during childbirth. It is also used to treat certain types of bacterial infections in the breasts, including mastitis and breast abscesses.
Some of the key players operating in the benzathine cloxacillin intramammary infusion market are Boehringer Ingelheim, Zoetis, Merck, Fresenius Kabi iPSUM, Oriental Aolong, Huisheng Biological, Zhengzhou Bairui Animal Pharmaceutical Co., Ltd., ·.
The benzathine cloxacillin intramammary infusion market is expected to register a CAGR of 5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Benzathine Cloxacillin Intramammary Infusion Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Benzathine Cloxacillin Intramammary Infusion Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Benzathine Cloxacillin Intramammary Infusion Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Benzathine Cloxacillin Intramammary Infusion Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Benzathine Cloxacillin Intramammary Infusion Market Size & Forecast, 2020-2028
4.5.1 Benzathine Cloxacillin Intramammary Infusion Market Size and Y-o-Y Growth
4.5.2 Benzathine Cloxacillin Intramammary Infusion Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10ml：0.5g
5.2.2 250m1：12.5g
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Retail
6.2.2 Online Sale
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Benzathine Cloxacillin Intramammary Infusion Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Benzathine Cloxacillin Intramammary Infusion Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10ml：0.5g
9.6.2 250m1：12.5g
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Retail
9.10.2 Online Sale
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10ml：0.5g
10.6.2 250m1：12.5g
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Retail
10.10.2 Online Sale
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10ml：0.5g
11.6.2 250m1：12.5g
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Retail
11.10.2 Online Sale
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10ml：0.5g
12.6.2 250m1：12.5g
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Retail
12.10.2 Online Sale
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10ml：0.5g
13.6.2 250m1：12.5g
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Retail
13.10.2 Online Sale
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Benzathine Cloxacillin Intramammary Infusion Market: Competitive Dashboard
14.2 Global Benzathine Cloxacillin Intramammary Infusion Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Boehringer Ingelheim
14.3.2 Zoetis
14.3.3 Merck
14.3.4 Fresenius Kabi iPSUM
14.3.5 Oriental Aolong
14.3.6 Huisheng Biological
14.3.7 Zhengzhou Bairui Animal Pharmaceutical Co., Ltd.
14.3.8 ·
